mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant-Reference-Cited by-同舟云学术

mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant

Published:2022-02 Issue:2 Volume:3 Page:100529
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Edara Venkata-Viswanadh,Manning Kelly E.,Ellis Madison,Lai Lilin,Moore Kathryn M.,Foster Stephanie L.,Floyd Katharine,Davis-Gardner Meredith E.,Mantus Grace,Nyhoff Lindsay E.,Bechnak Sarah,Alaaeddine Ghina,Naji Amal,Samaha Hady,Lee Matthew,Bristow Laurel,Gagne Matthew,Roberts-Torres Jesmine,Henry Amy R.,Godbole Sucheta,Grakoui Arash,Saxton Marybeth,Piantadosi Anne,Waggoner Jesse J.,Douek Daniel C.,Rouphael Nadine,Wrammert Jens,Suthar Mehul S.^ORCID

Funder

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference13 articles.

1. Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase;El Sahly;N. Engl. J. Med.,2021

2. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N. Engl. J. Med.,2021

3. An mRNA vaccine against SARS-CoV-2 - preliminary report;Jackson;N. Engl. J. Med.,2020

4. Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants;Pegu;Science,2021

5. Durability of immune responses to the BNT162b2 mRNA vaccine;Suthar;bioRxiv,2021

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pan-beta-coronavirus subunit vaccine prevents SARS-CoV-2 Omicron, SARS-CoV, and MERS-CoV challenge;Journal of Virology;2024-08-27

2. Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways;Nature Communications;2024-08-12

3. Eosinophils protect against SARS-CoV-2 following a vaccine breakthrough infection;2024-08-10

4. Update on Omicron variant and its threat to vulnerable populations;Public Health in Practice;2024-06

5. A Unique mRNA Vaccine Elicits Protective Efficacy against the SARS-CoV-2 Omicron Variant and SARS-CoV;Vaccines;2024-06-01